✦ LIBER ✦

Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial

✍ Scribed by Vermeire, Séverine; O'Byrne, Sharon; Keir, Mary; Williams, Marna; Lu, Timothy T; Mansfield, John C; Lamb, Christopher A; Feagan, Brian G; Panes, Julian; Salas, Azucena; Baumgart, Daniel C; Schreiber, Stefan; Dotan, Iris; Sandborn, William J; Tew, Gaik W; Luca, Diana; Tang, Meina T; Diehl, Lauri; Eastham-Anderson, Jeffrey; De Hertogh, Gert; Perrier, Clementine; Egen, Jackson G; Kirby, John A; van Assche, Gert; Rutgeerts, Paul

Book ID: 123559314
Publisher: The Lancet
Year: 2014
Tongue: English
Weight: 626 KB
Volume: 384
Category: Article
ISSN: 0140-6736
DOI: 10.1016/S0140-6736(14)60661-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Trichuris suis therapy for active ulcera

Trichuris suis therapy for active ulcerative colitis: A randomized controlled trial

✍ Robert W. Summers; David E. Elliott; Joseph F. Urban Jr; Robin A. Thompson; Joel 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 265 KB

943b Induction Therapy for Ulcerative Co

943b Induction Therapy for Ulcerative Colitis: Results of GEMINI I, a Randomized, Placebo-Controlled, Double-Blind, Multicenter Phase 3 Trial

✍ B.G. Feagan; P.J. Rutgeerts; B.E. Sands; J. Colombel; W.J. Sandborn; J. Colombel 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 93 KB

Adalimumab for induction of clinical rem

Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial

✍ Reinisch, Walter (author);Sandborn, William J. (author);Hommes, Daniel W. (autho 📂 Article 📅 2011 🏛 BMJ Publishing Group 🌐 English ⚖ 302 KB

Adalimumab for induction of clinical rem

Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial

✍ Reinisch, Walter (author);Sandborn, William J. (author);Hommes, Daniel W. (autho 📂 Article 📅 2011 🏛 BMJ Publishing Group 🌐 English ⚖ 302 KB

Adalimumab for induction of clinical rem

Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial

✍ Reinisch, Walter (author);Sandborn, William J. (author);Hommes, Daniel W. (autho 📂 Article 📅 2011 🏛 BMJ Publishing Group 🌐 English ⚖ 302 KB

Once Daily Mesalazine as Maintenance The

Once Daily Mesalazine as Maintenance Therapy for Ulcerative Colitis (UC): A One-Year Single-Blind Randomised Trial

✍ Antony B. Hawthorne; Rachel Stenson; David Gillespie; Edwin T. Swarbrick; Anjan 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 186 KB